Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Aurobindo Seeks To Boost India Business With Veritaz Acquisition
Indian Pharma Firm Has Paid INR1.71bn For Domestic Formulations Business
Mar 30 2022
•
By
Chloe Kent
Aurobindo's India business currently contributes to 12% of its revenue • Source: Alamy
More from Deals
More from Business
